Myeloproliferative neoplasms (MPNs) are a group of rare chronic blood cancers that are often challenging to treat,with few approved treatments currently available. Researchers at MD Anderson's Hanns A. Pielenz Clinical Research Center for Myeloproliferative Neoplasms are working to better understand the diseases and find new, more effective medications to treat patients with MPNs. 

To learn more about this group of...